Each year, in the United States, more than 650,000 men receive a negative prostate biopsy result, with around 25-35% of these results being false negative. However, a new prostate cancer test has been launched by MdxHealth. The test – ConfirmMDx™ for…
Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital. In such cases, the same research showed the experience…
Men who carry the mutated BRCA1 gene have a four times greater chance of developing prostate cancer than other males, researchers from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust reported in the British Cancer Journal. T…
In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects,…
Each year in the UK alone, about 37,000 men are diagnosed with prostate cancer. Given that prostate cancers can be genetically quite different, means they affect the way in which they react to treatments…
Society of Interventional Radiology showcases minimally invasive option to surgery that relieves lower urinary tract symptoms, helps men get their lives back. A new interventional radiology treatment, prostatic artery embolization, may bring hope to me…
Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH), a benign enlargement of the prostate that appears in aging men and is associated with …
An interesting and relatively simple piece of research into prostate cancer has been released this week. It is one that you might have thought would have been done a lot sooner. The paper shows evidence that supports circumcision in reduction of prosta…
A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymp…
Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine. “Treatment can do more harm than good in some instances,” said se…
